Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 156 Cr
P/E 15.60
Div Yield 0.00 %
Book Value βΉ82.80
52w High βΉ182.00
52w Low βΉ99.20
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
56.80
69.63
62.94
62.60
53.38
49.04
40.22
48.36
50.12
46.37
50.99
42.61
48.74
Expenses
52.49
64.75
56.09
54.52
45.94
42.41
35.95
41.12
41.50
40.58
45.02
37.32
42.24
Operating Profit
4.31
4.88
6.85
8.08
7.44
6.63
4.27
7.24
8.62
5.79
5.97
5.29
6.50
OPM %
7.59
7.01
10.88
12.91
13.94
13.52
10.62
14.97
17.20
12.49
11.71
12.41
13.34
Other Income
0.15
1.76
-0.17
0.63
0.18
0.43
0.19
0.95
0.11
0.25
0.10
0.22
0.24
Depreciation
2.22
2.04
1.96
2.10
1.94
1.83
1.79
1.94
1.83
1.84
1.78
1.74
1.60
Interest
1.64
1.61
1.47
1.40
1.22
1.28
1.23
1.38
1.50
1.41
1.35
1.43
1.16
Profit before tax
0.60
2.99
3.25
5.21
4.46
3.95
1.44
4.87
5.40
2.79
2.94
2.34
3.98
Tax %
28.33
27.09
16.62
30.33
26.46
26.08
16.67
29.77
26.30
19.35
25.85
20.09
16.33
Net Profit
0.43
2.19
2.71
3.62
3.28
2.93
1.21
3.42
3.99
2.24
2.18
1.87
3.33
EPS in Rs
0.37
1.90
2.36
3.16
2.85
2.54
1.05
2.97
3.47
1.95
1.90
1.63
2.89
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
249.00 188.00 189.00 168.00 163.00 90.00 95.00 109.00 106.00 95.00 71.00 103.00
Expenses
221.00 161.00 165.00 145.00 140.00 80.00 89.00 99.00 95.00 82.00 61.00 91.00
Operating Profit
27.00 27.00 24.00 23.00 23.00 10.00 6.00 10.00 10.00 13.00 10.00 12.00
OPM %
11.00 14.00 12.00 14.00 14.00 11.00 7.00 9.00 10.00 14.00 14.00 12.00
Other Income
2.00 1.00 1.00 1.00 0.00 0.00 1.00 2.00 1.00 0.00 1.00 1.00
Interest
6.00 5.00 5.00 5.00 5.00 5.00 5.00 4.00 4.00 5.00 4.00 4.00
Depreciation
8.00 7.00 7.00 7.00 6.00 5.00 4.00 4.00 4.00 4.00 3.00 3.00
Profit before tax
16.00 16.00 12.00 12.00 12.00 0.00 -2.00 5.00 3.00 5.00 3.00 5.00
Tax %
26.00 26.00 20.00 30.00 33.00 350.00 48.00 28.00 65.00 22.00 28.00 22.00
Net Profit
12.00 12.00 10.00 9.00 8.00 0.00 -3.00 3.00 1.00 4.00 3.00 4.00
EPS in Rs
10.26 10.03 8.37 7.51 8.40 -0.42 -3.42 3.88 1.23 4.33 2.95 5.01
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
11.00 11.00 11.00 11.00 10.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00
Reserves
84.00 72.00 60.00 51.00 38.00 24.00 24.00 27.00 24.00 23.00 19.00 17.00
Borrowings
83.00 70.00 81.00 55.00 69.00 59.00 51.00 42.00 37.00 39.00 42.00 41.00
Other Liabilities
50.00 37.00 38.00 28.00 36.00 15.00 23.00 17.00 18.00 15.00 10.00 17.00
Total Liabilities
228.00 190.00 190.00 145.00 153.00 106.00 107.00 95.00 87.00 86.00 79.00 83.00
Fixed Assets
115.00 88.00 89.00 77.00 72.00 60.00 58.00 51.00 44.00 47.00 38.00 36.00
CWIP
11.00 29.00 21.00 2.00 3.00 5.00 3.00 0.00 0.00 0.00 2.00 1.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 1.00
Other Assets
101.00 72.00 80.00 66.00 78.00 41.00 46.00 43.00 43.00 38.00 38.00 45.00
Total Assets
228.00 190.00 190.00 145.00 153.00 106.00 107.00 95.00 87.00 86.00 79.00 83.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
8.00 32.00 16.00 21.00 9.00 6.00 9.00 9.00 13.00 16.00 3.00 0.00
Cash from Investing Activity
-16.00 -16.00 -32.00 -10.00 -16.00 -7.00 -13.00 -11.00 -5.00 -10.00 -6.00 -4.00
Cash from Financing Activity
8.00 -16.00 15.00 -14.00 12.00 0.00 5.00 1.00 -7.00 -5.00 1.00 6.00
Net Cash Flow
0.00 0.00 -1.00 -3.00 4.00 0.00 0.00 -1.00 1.00 0.00 -2.00 1.00
Free Cash Flow
-9.00 16.00 -16.00 11.00 -8.00 0.00 -4.00 -3.00 8.00 5.00 -3.00 -4.00
CFO/OP %
42.00 130.00 79.00 103.00 38.00 71.00 153.00 99.00 134.00 134.00 46.00 15.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
56.00 60.00 63.00 61.00 85.00 68.00 88.00 64.00 65.00 72.00 100.00 84.00
Inventory Days
90.00 87.00 94.00 79.00 73.00 80.00 76.00 52.00 45.00 50.00 64.00 38.00
Days Payable
80.00 72.00 74.00 53.00 81.00 46.00 74.00 44.00 45.00 48.00 30.00 51.00
Cash Conversion Cycle
65.00 75.00 83.00 86.00 77.00 102.00 90.00 72.00 64.00 74.00 134.00 71.00
Working Capital Days
-11.00 -24.00 -23.00 -19.00 -35.00 -66.00 -31.00 0.00 -8.00 -26.00 7.00 16.00
ROCE %
14.00 14.00 13.00 15.00 17.00 6.00 3.00 12.00 11.00 14.00 11.00 16.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
72.30
72.30
72.30
72.30
72.30
72.30
72.30
72.30
72.30
72.30
72.30
72.30
Public
27.71
27.71
27.70
27.71
27.70
27.70
27.71
27.71
27.70
27.70
27.70
27.69
No. of Shareholders
3,572
3,721
3,900
4,111
4,317
4,440
4,521
4,173
4,406
4,496
3,536
3,543
Back to all stocks